Insider Trading & Ownership of Cambridge Equities, LP
-
Location
-
El Segundo, CA
-
Summary
-
The estimated value of insider holdings of Cambridge Equities, LP is at least $572,646,382 dollars as of 20 Feb 2024. Cambridge Equities, LP is the 10%+ Owner of ImmunityBio, Inc. and owns shares of ImmunityBio, Inc. (IBRX) stock worth about $571.73M. Cambridge Equities, LP is the 10%+ Owner of Heliogen, Inc. and owns shares of Heliogen, Inc. stock worth about $915.6K.
-
Signature
-
//s/ Charles Kenworthy, Manager of MP 13 Ventures, on behalf of itself and as General Partner of Cambridge Equities
Follow Filing Activity
Follow Cambridge Equities, LP and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Quick Takeaways
- Cambridge Equities, LP has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $572,646,382.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: ImmunityBio, Inc. ($571,730,825).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Cambridge Equities, LP
Insider Transactions Reported by Cambridge Equities, LP:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.